Nucleolar organizer regions in optic gliomas

Area of Science:

• Neuro-oncology
• Pathology
• Ophthalmology

Background:

• The classification of optic gliomas remains controversial, with ongoing debate regarding their nature as benign hamartomas or true neoplasms.
• Distinguishing between benign and malignant lesions is crucial for appropriate clinical management and patient outcomes.

Purpose of the Study:

• To investigate the utility of nucleolar organizer region-associated proteins (AgNORs) staining in differentiating optic gliomas from other optic nerve lesions.
• To determine if AgNOR counts can help classify optic gliomas as benign hamartomas or true neoplasms.

Main Methods:

• Colloid silver impregnation was used to stain AgNORs in 31 optic gliomas, 14 optic nerve meningiomas, and one giant cell glioblastoma multiforme.
• AgNORs were counted in a masked fashion per nucleus for each lesion type.
• AgNOR counts were compared between optic gliomas, optic nerve meningiomas, reactive astrocytosis, and diffuse fibrillary astrocytoma.

Main Results:

• Optic gliomas exhibited significantly higher AgNOR counts (2.01 +/- 0.09 per nucleus) compared to reactive astrocytosis (1.18 +/- 0.02).
• AgNOR counts in optic gliomas were comparable to those in optic nerve meningiomas (2.15 +/- 0.15) and diffuse fibrillary astrocytoma (2.22 +/- 0.10).
• Six out of seven optic gliomas displayed compound AgNORs, a marker associated with malignancy in other tumor types.

Conclusions:

• The elevated AgNOR counts and presence of compound AgNORs in optic gliomas suggest they are true neoplasms rather than benign hamartomas.
• AgNOR staining may serve as a valuable tool in the pathological assessment of optic nerve lesions.
• Further research is warranted to fully elucidate the biological behavior and optimal treatment strategies for optic gliomas.